Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03285399
Other study ID # 172226
Secondary ID
Status Completed
Phase N/A
First received September 13, 2017
Last updated September 15, 2017
Start date January 12, 2008
Est. completion date February 28, 2014

Study information

Verified date September 2017
Source Centre For International Health
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Between February 2008 and February 2009, 500 infant-mother pairs in Bhaktapur, Nepal were randomly selected in this nutritional survey. The dietary intake, nutritional status of several nutrients, growth, and breastfeeding habits were measured in both the women and their infants.The objective of this first phase was to estimate the intake and status of several nutrients in relation to breastfeeding. These mother-child pairs were revisited around the child's fifth birthday when growth, diet, and neurodevelopment was measured. The objective of this phase was to create a cohort study where factors in infancy could be related with health outcomes and development 5 years later.


Description:

Over a period of one year, a total of 500 lactating (encompassing both exclusive and partial breastfeeding) women were enrolled in the study and completed the first 24-hour dietary recall. The women attended a hospital for physical examination, dietary interview, and blood sampling. Blood samples were also collected from their infants who also went through a detailed clinical examination

The blood samples from mothers and infant pairs were collected approximately one week apart. The blood was spun down, plasma separated and transferred into storage vials immediately. Plasma and blood pellets were stored in cryovials at -70 until analysis.

All women were also requested to provide one breast milk and one urine sample.

Plasma, blood pellet, urine, and breast milk was stored at -70 degrees celcius until analysis.

Plasma was analyzed for iron, transferrin receptor, ferritin, cobalamin, folate, vitamin A, vitamin D, vitamin E, several amino acids and other micronutrient related metabolites.

The breast milk will be analyzed for iodine, fatty acids, and several B vitamins

The urine was analyzed for iodine.

In phase 2, after 5 years we revisited the mother-child pairs and measured growth, diet, food security, and neurodevelopment.


Recruitment information / eligibility

Status Completed
Enrollment 1000
Est. completion date February 28, 2014
Est. primary completion date February 28, 2010
Accepts healthy volunteers No
Gender All
Age group 2 Months to 11 Months
Eligibility Inclusion Criteria:

- availability of consent

- no ongoing illness

- resides in the selected cluster

- that household information could be obtained

- that the mother was lactating

Exclusion Criteria:

- refused blood sampling

- chronic illness

Study Design


Locations

Country Name City State
Nepal Siddhi Memorial Hospital (SMH),Bhelukhel, Bhimsensthan Bhaktapur

Sponsors (4)

Lead Sponsor Collaborator
Centre For International Health Harvard School of Public Health, Oslo and Akershus University of Applied Sciences, Tribhuvan University, Nepal

Country where clinical trial is conducted

Nepal, 

Outcome

Type Measure Description Time frame Safety issue
Primary Prevalence of micronutrient deficiency The status and prevalence of deficiencies of several micronutrients has been estimated 1 year
Primary Predictors for micronutrient status We will estimate predictors for several of the measured micronutrients using other biomarkers and clinical and demographic variables. 1 year
Primary Prevalence of anaemia in mothers and children Hemoglobin concentration is measured for all participants and the proportion anaemic and predictors for anaemia will be presented. 1 year
Secondary Neurodevelopment at 5 years Neurodevelopment is measured when the children are 5 using the Ages and Stages questionnaire and the NEPSY II tests. These measures will be related to micronutrient status, inflammation and stress markers. 5 years
Secondary Growth during infancy and at 5 years of age Growth (length and weight) is measured when the children are 5 years and will be related to nutritional status. 5 years
Secondary Markers of stress and inflammation. Maternal and infants markers of inflammation (CRP, neopterine, kynurenic acid, kynurenine, tryphtophane, etc) and stress (leucocyte telomere length) will be measured and related to micronutrient status. 1 year
Secondary Breastmilk b-vitamin concentration The concentration of several b-vitamins will be estimated in the breast milk and related to dietary intake and maternal and child status 1 year
See also
  Status Clinical Trial Phase
Completed NCT05729828 - Psychometric Properties of the SMART Feeding Tool
Not yet recruiting NCT06372418 - Providing Breastfeeding Support After Discharge From Hospital to Improve Growth and Development of Malnourished Infants N/A
Completed NCT02516852 - Assessing the Effect of Sustainable Small-scale Egg Production on Maternal and Child Nutrition in Rural Zambia N/A
Recruiting NCT05826769 - To Assess the Efficacy of Early Administration of Energy Enriched and Protein Enriched Formula in Post Cardiac Repair Infants: a Randomized Controlled Trial, Comparative Study N/A
Recruiting NCT04992104 - Microbiome and Malnutrition in Pregnancy
Not yet recruiting NCT05590351 - Promotion of Exclusive Breast Feeding and Young Child Feeding Practices Through m-Health N/A